Cle De Peau Beaute Radiant Cream To Powder Foundation

List of products in the National Drug Code with proprietary name cle de peau beaute radiant cream to powder foundation.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
58411-427Cle De Peau Beaute Radiant Cream To Powder Foundation I10Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-428Cle De Peau Beaute Radiant Cream To Powder Foundation O10Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-429Cle De Peau Beaute Radiant Cream To Powder Foundation O20Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-430Cle De Peau Beaute Radiant Cream To Powder Foundation O30Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-431Cle De Peau Beaute Radiant Cream To Powder Foundation O40Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-432Cle De Peau Beaute Radiant Cream To Powder Foundation O50Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-433Cle De Peau Beaute Radiant Cream To Powder Foundation O60Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-434Cle De Peau Beaute Radiant Cream To Powder Foundation B10Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-435Cle De Peau Beaute Radiant Cream To Powder Foundation B20Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-436Cle De Peau Beaute Radiant Cream To Powder Foundation B30Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-437Cle De Peau Beaute Radiant Cream To Powder Foundation BF20Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug
58411-438Cle De Peau Beaute Radiant Cream To Powder Foundation WB20Octinoxate And Titanium DioxideCreamTopicalShiseido Americas CorporationHuman Otc Drug